Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Denton

Showing results (91-100 of 484) with videos related to

Pageof 49
Sort By:
Rheumatology (Oxford, England)|April 30, 2010
Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosisAriane L Herrick, Mark Lunt, Alan J Silman, et al.
The Journal of Investigative Dermatology|June 17, 2014
Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9Joanna Nikitorowicz-Buniak, Xu Shiwen, Christopher P Denton, et al.
Rheumatology (Oxford, England)|February 14, 2026
Advancing drug development for systemic sclerosis by prioritising findings from human genetic association studiesMichael Hughes, Zsuzsanna H McMahan, Shervin Assassai, et al.
Journal of the American Academy of Dermatology|February 8, 2022
Systemic sclerosis in adults. Part I: Clinical features and pathogenesisRebekka Jerjen, Mandana Nikpour, Thomas Krieg, et al.
Aesthetic Surgery Journal|September 26, 2024
Fat Grafting and Adipose Stem Cells for Facial Systemic Sclerosis: A Systematic Review of the LiteratureAurora Almadori, Sze Ching Fung, Christopher P Denton, et al.
Arthritis and Rheumatism|August 29, 2009
Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse modelShangxi Liu, Mohit Kapoor, Christopher P Denton, et al.
Journal of Cell Communication and Signaling|April 23, 2009
Pericytes display increased CCN2 expression upon culturingXu Shiwen, Vineeth Rajkumar, Christopher P Denton, et al.
Molecular Biology of the Cell|November 17, 2017
STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis posttranscriptionally, and is essential for lung myofibroblast differentiationIoannis Papaioannou, Shiwen Xu, Christopher P Denton, et al.
Journal of the American Academy of Dermatology|February 8, 2022
Systemic sclerosis in adults. Part II: management and therapeuticsRebekka Jerjen, Mandana Nikpour, Thomas Krieg, et al.
Arthritis Research & Therapy|September 15, 2007
Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue diseaseLewis J Rubin, Carol M Black, Christopher P Denton, et al.
Pageof 49

Showing results (91-100 of 484) with videos related to

Sort By:
Pageof 49
Rheumatology (Oxford, England)|April 30, 2010
Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosisAriane L Herrick, Mark Lunt, Alan J Silman, et al.
The Journal of Investigative Dermatology|June 17, 2014
Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9Joanna Nikitorowicz-Buniak, Xu Shiwen, Christopher P Denton, et al.
Rheumatology (Oxford, England)|February 14, 2026
Advancing drug development for systemic sclerosis by prioritising findings from human genetic association studiesMichael Hughes, Zsuzsanna H McMahan, Shervin Assassai, et al.
Journal of the American Academy of Dermatology|February 8, 2022
Systemic sclerosis in adults. Part I: Clinical features and pathogenesisRebekka Jerjen, Mandana Nikpour, Thomas Krieg, et al.
Aesthetic Surgery Journal|September 26, 2024
Fat Grafting and Adipose Stem Cells for Facial Systemic Sclerosis: A Systematic Review of the LiteratureAurora Almadori, Sze Ching Fung, Christopher P Denton, et al.
Arthritis and Rheumatism|August 29, 2009
Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse modelShangxi Liu, Mohit Kapoor, Christopher P Denton, et al.
Journal of Cell Communication and Signaling|April 23, 2009
Pericytes display increased CCN2 expression upon culturingXu Shiwen, Vineeth Rajkumar, Christopher P Denton, et al.
Molecular Biology of the Cell|November 17, 2017
STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis posttranscriptionally, and is essential for lung myofibroblast differentiationIoannis Papaioannou, Shiwen Xu, Christopher P Denton, et al.
Journal of the American Academy of Dermatology|February 8, 2022
Systemic sclerosis in adults. Part II: management and therapeuticsRebekka Jerjen, Mandana Nikpour, Thomas Krieg, et al.
Arthritis Research & Therapy|September 15, 2007
Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue diseaseLewis J Rubin, Carol M Black, Christopher P Denton, et al.
Pageof 49